FIBBI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.657
EU - Europa 8.315
AS - Asia 5.077
SA - Sud America 574
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 126
OC - Oceania 90
Totale 27.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.438
RU - Federazione Russa 2.488
PL - Polonia 1.585
SG - Singapore 1.484
IT - Italia 1.444
CN - Cina 1.177
HK - Hong Kong 792
SE - Svezia 658
IE - Irlanda 576
VN - Vietnam 477
BR - Brasile 434
KR - Corea 420
DE - Germania 320
FI - Finlandia 287
UA - Ucraina 260
GB - Regno Unito 220
FR - Francia 166
IN - India 143
BD - Bangladesh 132
CA - Canada 124
NL - Olanda 123
JO - Giordania 121
AU - Australia 89
JP - Giappone 79
ID - Indonesia 66
AR - Argentina 45
CH - Svizzera 37
TR - Turchia 37
BE - Belgio 36
IQ - Iraq 34
CI - Costa d'Avorio 32
MX - Messico 32
AT - Austria 29
CO - Colombia 24
EC - Ecuador 24
ES - Italia 19
ZA - Sudafrica 19
CR - Costa Rica 17
PH - Filippine 16
VE - Venezuela 16
PK - Pakistan 14
SA - Arabia Saudita 13
UZ - Uzbekistan 13
NG - Nigeria 11
SC - Seychelles 11
MA - Marocco 10
CL - Cile 9
JM - Giamaica 9
LT - Lituania 9
LV - Lettonia 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
GT - Guatemala 7
NI - Nicaragua 7
PE - Perù 7
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
IL - Israele 6
SN - Senegal 6
TT - Trinidad e Tobago 6
GR - Grecia 5
KZ - Kazakistan 5
MY - Malesia 5
NO - Norvegia 5
RO - Romania 5
TN - Tunisia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
LB - Libano 4
OM - Oman 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BG - Bulgaria 3
BS - Bahamas 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HR - Croazia 3
MD - Moldavia 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
TW - Taiwan 3
BJ - Benin 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
HU - Ungheria 2
IR - Iran 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 26.826
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.299
Warsaw 1.581
Ashburn 1.440
Singapore 1.068
Fairfield 864
Chandler 746
Hong Kong 659
Dublin 575
San Jose 566
Jacksonville 441
Woodbridge 424
Seoul 414
Seattle 387
Cambridge 325
Houston 318
Wilmington 288
Beijing 272
Ann Arbor 267
Milan 261
Council Bluffs 236
Buffalo 226
Hefei 213
Los Angeles 199
Florence 183
The Dalles 163
Princeton 156
Ho Chi Minh City 132
Helsinki 127
Rome 121
Altamura 111
Lawrence 111
Lauterbourg 109
Amsterdam 107
Boston 106
Boardman 103
Munich 100
Hanoi 98
Moscow 96
New York 93
Dallas 87
Melbourne 84
Shanghai 82
Medford 76
Mumbai 75
Tokyo 75
Phoenix 66
Chicago 63
San Diego 55
Jakarta 45
Turku 39
London 38
São Paulo 36
Brussels 35
Clifton 35
Toronto 35
Kent 34
Naples 33
Abidjan 32
Dong Ket 31
Bern 30
Columbus 30
Figino 30
Turin 28
Vienna 28
Bologna 25
North Bergen 25
Norwalk 25
Da Nang 24
Orem 24
Redondo Beach 23
West Jordan 22
Brooklyn 21
Paris 21
Bari 20
Guangzhou 20
Haiphong 20
Genoa 19
Catania 18
Frankfurt am Main 18
Hillsboro 18
Falls Church 17
Verona 17
Yubileyny 17
Baghdad 16
Izmir 15
Pune 15
Brasília 14
Montreal 14
Palermo 14
Rio de Janeiro 14
Salerno 14
San José 14
Bengaluru 13
Denver 13
Philadelphia 13
Frankfurt Am Main 12
San Francisco 12
Tashkent 12
Andover 11
Charlotte 11
Totale 17.808
Salva come PNG Salva come JPEG
Nome #
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 395
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 394
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 388
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 350
The acidic microenvironment as a possible niche of dormant tumor cells 326
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 322
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 319
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 314
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 303
Type II CRISPR/Cas9 approach in the oncological therapy 297
Anoikis resistance as a further trait of acidic-adapted melanoma cells 292
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells 272
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 265
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 264
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 260
Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer. 247
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 241
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 240
GLYCOSAMINOGLYCANS AND EUKARIOTIC CELL CONTROL. 238
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 238
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 237
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 233
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 229
Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. 226
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 226
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 224
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 221
Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. 220
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES. 215
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 214
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 214
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis 213
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 212
Involvement of modulation of cell coat glycosaminoglycans in guinea pig peritoneal macrophage activity 211
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 211
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 209
Intercellular glycosaminoglycans in human cancer 208
Endothelial sphingosine kinase/SPNS2 axis has a critical role in migration and vessel-like formation of human mesoangioblasts 208
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. 200
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 200
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 199
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 198
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. 197
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 197
Divergent regulation of long non-coding RNAs H19 and PURPL affects cell senescence in human dermal fibroblasts. 196
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 196
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 196
I SINOVIOCITI DI ARTRITE REUMATOIDE (AR) PRESENTANO IL PATTERN FIBRINOLITICO DELLE CELLULE INVASIVE. REUMATISMO, 2001 VOL 53 N°3 (SUPPL. N° 4) 193
Delivery systems of CRISPR/Cas9-based cancer gene therapy 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 193
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 191
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 191
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. 190
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 189
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 188
Sulphated polysaccharides and the differentiation of the cellular slime mould Dictyostelium discoideum 188
Inhibition of spontaneous growth and induced differentiation of murine erythroleukaemia cells by paraquat and atrazine. 188
The "End Life" of the Grape Pomace Waste Become the New Beginning: The Development of a Virtuous Cycle for the Green Synthesis of Gold Nanoparticles and Removal of Emerging Contaminants from Water 186
Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. 186
I GLICOSAMINOGLICANI NELL'ADESIONE DEI LEUCOCITI POLIMORFONUCLEATI E DELLE PIASTRINE. 185
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. 185
TGFb1 antagonistic peptides inhibit TGFb1-dependent angiogenesis 185
Water diffusion effects at gold-graphene interfaces supporting surface plasmon polaritons 184
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters 184
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8 183
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 183
ELECTROPHORETIC CHARACTERIZATION OF SURFACE HEPARAN SULPHATES IN NORMAL AND VIRUS TRANSFORMED 3T3 CELLS. 183
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 183
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 181
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 180
Chronic treatment with resveratrol and olive oil phenols on MRC5 fibroblast SASP: inhibition of pro-tumoral microenvironment 179
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. 178
Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein 178
Adhesion-dependent heparin production by platelets. 177
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 177
Plasminogen activator: morphological evidence of binding, internalization and delivery to lysosomes in 3T3 mouse fibroblasts. 176
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 176
Pulsed-Laser-Driven CO2 Reduction Reaction for the Control of the Photoluminescence Quantum Yield of Organometallic Gold Nanocomposites 175
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression 174
bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity. 172
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 170
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 169
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 169
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 169
Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts 168
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice 167
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 167
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 167
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 165
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 164
CHARACTERIZATION OF FIBRINOLYTIC PATTERN OF SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS (RA). J RHEUMATOL , 28 (SUPPLEMENT 63) 164
Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells. 163
Parvovirus B19 (B19V) induces cellular senescence in human dermal fibroblasts: putative role in SSc-associated fibrosis. 163
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. 162
Plasminogen activators and inhibitor type-1 in alveolar osteitis. 161
Modulation of surface-associated urokinase: binding, interiorization, delivery to lysosomes, and degradation in human keratinocytes 158
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy 158
Interaction of urokinase A-chain with the cellular receptor induces both urokinase autocriny and cell movement. 157
Receptors for plasminogen activators, urokinase, in normal and Rous Sarcoma Virus-transformed mouse fibroblasts 156
SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS (RA) PRESENT FIBRINOLYTIC PATTERN OF THE INVASIVE CELLS. ARTHRITIS AND RHEUMATISM VOLUME 44, N°9 (SUPPLEMENT) 156
Prep1 regulates angiogenesis through a PGC-1α-mediated mechanism 156
Totale 20.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022854 0 0 0 53 41 55 30 75 60 49 225 266
2022/20232.810 272 458 128 239 235 482 352 210 307 12 61 54
2023/20241.016 34 118 145 46 60 151 39 278 14 62 38 31
2024/20256.684 236 684 415 1.023 2.009 871 90 417 263 151 290 235
2025/20267.820 907 1.014 562 649 837 312 967 372 556 457 216 971
2026/20271.436 264 255 674 243 0 0 0 0 0 0 0 0
Totale 27.045